A focused collection on GLP-1 medications and nutrition: appetite suppression, protein needs, muscle retention, and what changes when weight loss gets pharmacological.
A 2026 Annals of Oncology study of 229,000+ obese adults found GLP-1 drugs linked to a 41% drop in obesity-related cancer risk. Here's what the data shows, and what to eat to make the most of it.
Welling is Reddit's top AI coaching tracker at $79/year. Aumaï coaches via WhatsApp with persistent memory at €4.99/month. Here's the honest head-to-head.
A phase 3 trial of survodutide, a dual GLP-1 plus glucagon drug, reported 16.6% weight loss over 76 weeks. As appetite suppression gets stronger, the food side gets harder, not easier.
Noom has pivoted to GLP-1 medications and costs up to $60/month. Here is how it compares to Aumaï AI nutrition coach at 4.99/month.
A Stanford and ETH Zurich study found about 10% of people carry PAM gene variants linked to GLP-1 resistance, which may reduce how effectively Ozempic lowers blood sugar.
A tiny 12-amino-acid peptide called BRP may curb appetite like semaglutide, without the nausea or muscle loss. Stanford researchers used AI to find it.
Aumaï